Printer Friendly

A. L. LABORATORIES REPORTS FIRST QUARTER EARNINGS

 FORT LEE, N.J., May 11 /PRNewswire/ -- A. L. Laboratories, Inc. (NYSE: BMD) today reported that for its first quarter ended March 31, 1993, net income from continuing operations was $3,917,000 versus $3,568,000 in the comparable quarter of 1992. Revenue from continuing operations increased to $77,788,000 compared with $71,216,000 in the same period a year ago. Per share earnings from continuing operations on a fully diluted basis were $.18 in 1993 versus $.20 in 1992. Total net income for the first quarter of 1992, which included income from discontinued operations, was $3,956,000, or $.22 per share.
 A. L. Laboratories is a multinational manufacturer and marketer of specialized and value-added branded pharmaceuticals and animal health micronutrients, with plant sites in Illinois, Maryland, New Jersey, New York, North Carolina, Washington State, Denmark and Indonesia.
 A. L. LABORATORIES, INC.
 Consolidated Statement of Income
 (In thousands, except per share data, unaudited)
 Three Months Ended March 31, 1993 1992
 Total revenue $77,788 $71,216
 Cost of sales 44,740 38,956
 Gross profit 33,048 32,260
 Selling, general and
 administrative expenses 25,070 23,378
 Operating income 7,978 8,882
 Interest expense (1,606) (3,071)
 Other, net 156 236
 Income from continuing operations
 before provision for income taxes 6,528 6,047
 Provision for income taxes 2,611 2,479
 Income from continuing
 operations 3,917 3,568
 Income from discontinued
 operations, net of tax -- 388
 Net income $ 3,917 $ 3,956
 Average common shares outstanding:
 Primary 21,492 17,086
 Fully diluted 21,601 21,558
 Earnings per common share:
 Primary
 Income from continuing operations $ .18 $ .21
 Net income $ .18 $ .23
 Fully diluted
 Income from continuing operations $ .18 $ .20
 Net income $ .18 $ .22
 Dividend per common share $ .045 $ .045
 A. L. LABORATORIES, INC.
 Financial Position
 (In thousands)
 March 31, 1993 Dec. 31, 1992
 (unaudited) (audited)
 Current assets $149,441 $155,372
 Non-current assets 233,613 216,352
 Total assets $383,054 $371,724
 Current liabilities $ 79,641 $ 87,490
 Long-term debt 89,568 73,651
 Deferred taxes and other
 liabilities 26,664 26,458
 Stockholders' equity 187,181 184,125
 Total liabilities and
 stockholders' equity $383,054 $371,724
 -0- 5/11/93
 /CONTACT: Iris D. Daniels, investor relations manager of A. L. Laboratories, 201-947-7774, or David Walke of Morgen-Walke Associates, 212-986-5900, for A. L. Laboratories/
 (BMD)


CO: A. L. Laboratories, Inc. ST: New Jersey IN: MTC SU: ERN

LD -- NY005 -- 6801 05/11/93 07:31 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 11, 1993
Words:418
Previous Article:EPIGEN REPORTS QUARTER FINANCIAL RESULTS
Next Article:NETMANAGE FIRST TO MARKET WITH TCP/IP PRODUCT FOR WINDOWS NT ON ALPHA; APPLICATIONS FOR WINDOWS NT TO BE SHOWN AT WINDOWS WORLD
Topics:


Related Articles
A. L. LABORATORIES REPORTS 1991 FULL-YEAR AND FOURTH QUARTER EARNINGS
A. L. LABORATORIES REPORTS FIRST QUARTER EARNINGS
A. L. LABORATORIES REPORTS THIRD QUARTER AND NINE MONTH RESULTS
A. L. LABORATORIES REPORTS 1992 FULL-YEAR AND FOURTH QUARTER EARNINGS
ABBOTT REPORTS INCREASE IN SALES, EARNINGS IN SECOND QUARTER; EARNINGS PER SHARE UP 13.5 PERCENT
A. L. LABORATORIES ELABORATES ON SECOND QUARTER EARNINGS RELEASE
A. L. LABORATORIES REPORTS SECOND QUARTER AND SIX MONTH RESULTS
FOREST LABORATORIES REPORTS RECORD FISCAL SECOND QUARTER RESULTS
A. L. LABORATORIES REPORTS THIRD QUARTER AND NINE MONTH RESULTS
A. L. LABORATORIES ISSUES CORRECTION TO IBES EARNINGS ESTIMATE FOR THE THIRD QUARTER 1993

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters